Join
Live feed
·
INSIDERFilingvia Quantisnow
Vanda Pharmaceuticals Inc. logo

Director Chrousos Phaedra was granted 59,225 shares, increasing direct ownership by 92% to 123,350 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VNDA· Vanda Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VNDA (Vanda Pharmaceuticals Inc.) and more on Quantisnow.